12 articles, transcripts, and reports
Novavax Inc (NASDAQ:NVAX) Q4 2022 Earnings Call dated Feb. 28, 2023. Corporate Participants: Erika Schultz — Senior Director of Investor Relations John Jacobs — President and Chief Executive Officer…
Novavax Inc (NASDAQ:NVAX) Q3 2022 Earnings Call dated Nov. 08, 2022. Corporate Participants: Silvia Taylor — Executive Vice President, Chief Communications Officer Stanley C. Erck — President and Chief…
Novavax, Inc. (NASDAQ: NVAX) Q4 2021 earnings call dated Feb. 28, 2022 Corporate Participants: Silvia Taylor — Senior Vice President of Global Corporate Affairs and Investor Relations…
Novavax Inc (NASDAQ: NVAX) Q4 2020 earnings call dated March. 01, 2021. Corporate Participants: Silvia Taylor — Senior Vice President, Investor Relations and Corporate Affairs Stanley C.…
Novavax Inc.’s (NASDAQ: NVAX) shares soared 50% in morning hours on Friday after the company announced that its COVID-19 vaccine candidate displayed an efficacy rate…
The market has been closely following the activities of leading biopharma companies for some time, looking for updates on their COVID vaccine programs. With most…
After Novavax (NASDAQ: NVAX) reported its progress on developing the COVID-19 vaccine at the end of February, the shares of the company started trading in…
Novavax Inc (NASDAQ: NVAX) Q2 2020 earnings call dated Aug. 10, 2020 Corporate Participants: Silvia Taylor — Senior Vice President, Investor Relations and Corporate Affairs Stanley C.…
Novavax (NASDAQ: NVAX) reported a loss of $17.5 million or $0.30 per share for the second quarter of 2020. Revenue jumped to $35.54 million in…
For Novavax Inc. (NASDAQ: NVAX), the new fiscal year is of great significance due to the progress it has achieved in developing Covid-19 vaccine. At…
